Product image of Lanxib (Lansoprazole) supplied by GNH India

Lanxib

Active Ingredient:
Lansoprazole
Origin:
EU

Lanxib (Lansoprazole)

Lansoprazole, the active ingredient in Lanxib, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid production and is prescribed for conditions such as gastro‑esophageal reflux disease, peptic ulcer disease, and erosive esophagitis.

GNH India supplies Lanxib as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU GMP standards and providing reliable logistics for global distribution.

Manufacturer / TM Owner

Farmak International Sp. Z O.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Lanxib (lansoprazole) is used to manage acid‑related gastrointestinal disorders.

  • Gastro‑esophageal reflux disease (GERD): alleviates heartburn and reflux symptoms by reducing stomach acid.
  • Peptic ulcer disease: promotes ulcer healing and prevents recurrence through acid suppression.
  • Helicobacter pylori eradication regimens: acts as a component of combination therapy to increase antibiotic efficacy.
  • Erosive esophagitis: facilitates mucosal healing by lowering gastric acidity.

How It Works

  • Lansoprazole selectively and irreversibly inhibits the H+/K+ ATPase enzyme (the gastric proton pump) located on the secretory surface of parietal cells. By blocking this final step of acid secretion, it markedly reduces both basal and stimulated gastric acid output, creating a less acidic gastric environment that supports healing of acid‑related lesions.

Side Effects

Adverse reactions may vary in frequency and severity.

Common Side Effects

  • Headache: mild to moderate pain often transient.
  • Diarrhea: loose stools occurring during treatment.
  • Nausea: feeling of sickness without vomiting.
  • Abdominal pain: discomfort or cramping in the stomach area.
  • Flatulence: increased intestinal gas.
  • Constipation: reduced bowel movements.

Serious or Rare Side Effects

  • Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing.
  • Clostridioides difficile infection: severe diarrhea with abdominal pain.
  • Low magnesium (hypomagnesemia): muscle cramps, irregular heartbeat.
  • Elevated liver enzymes: possible hepatitis signs.
  • Stevens‑Johnson syndrome/toxic epidermal necrolysis: severe skin blistering.
  • Interstitial nephritis: kidney inflammation presenting with fever and rash.

Precautions & Warnings

Before initiating therapy, consider the following safety measures.

  • Assess renal function: adjust use in patients with severe impairment.
  • Monitor magnesium levels: prolonged therapy may cause hypomagnesemia.
  • Use with caution in hepatic impairment: reduced metabolism may increase exposure.
  • Avoid in known hypersensitivity: discontinue if allergic signs appear.
  • Review concomitant medications: potential for clinically relevant interactions.
  • Store at room temperature: keep in the original pack, protect from moisture.

Avoid Interactions

Lansoprazole can affect the absorption or metabolism of several drugs.

Major Interactions (Avoid)

  • Clarithromycin: increased risk of cardiac arrhythmias.
  • Ketoconazole: markedly reduced antifungal absorption.
  • Atazanavir: decreased antiviral efficacy.
  • Rilpivirine: diminished HIV‑1 viral suppression.
  • Voriconazole: altered antifungal plasma levels.

Moderate Interactions (Monitor Closely)

  • Digoxin: increased serum concentrations.
  • Methotrexate: reduced clearance, risk of toxicity.
  • Warfarin: enhanced anticoagulant effect.
  • Diazepam: elevated plasma levels.
  • Iron salts: decreased iron absorption.

Frequently Asked Questions

Lanxib is prescribed for acid‑related gastrointestinal disorders such as gastro‑esophageal reflux disease, peptic ulcer disease, Helicobacter pylori eradication regimens, and erosive esophagitis. It helps reduce stomach acidity, relieving symptoms and promoting healing of the affected mucosa.

Lansoprazole blocks the H+/K+ ATPase enzyme, also known as the gastric proton pump, on the surface of parietal cells. This inhibition prevents the final step of acid secretion, leading to a sustained decrease in gastric acidity and allowing ulcerated tissue to heal.

The appropriate dose of Lanxib is determined by the prescribing clinician based on the specific indication, patient age, renal and hepatic function, and other individual factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for lansoprazole in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any potential risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the Lanxib product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lanxib (lansoprazole) belongs to the same class as omeprazole, esomeprazole and pantoprazole. All PPIs share a similar mechanism of acid suppression, but differences exist in pharmacokinetics, drug‑interaction profiles and dosing frequency. Choice of agent is usually based on clinician preference, patient response and specific interaction considerations.

Lanxib should be stored at room temperature, below 25 °C, in its original packaging. Protect the tablets from moisture and direct sunlight to maintain stability throughout its shelf life.

Lanxib is taken orally, usually as a whole tablet with a glass of water. It is commonly recommended to take the dose before a meal, but patients should follow the specific timing advised by their prescriber.

Serious adverse events, though rare, include severe allergic reactions (anaphylaxis), Clostridioides difficile‑associated diarrhea, low magnesium levels, liver enzyme elevations, Stevens‑Johnson syndrome and interstitial nephritis. Patients should seek immediate medical attention if they experience any of these symptoms.

Lanxib is contraindicated in individuals with known hypersensitivity to lansoprazole or any component of the formulation. Caution is advised for patients with severe liver disease, those taking medications that require an acidic gastric environment, and patients with certain electrolyte disturbances.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Lansoprazole

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT